Sonnet BioTherapeutics I... (SONN)
NASDAQ: SONN
· Real-Time Price · USD
1.16
0.01 (0.87%)
At close: Jun 16, 2025, 3:59 PM
1.17
0.79%
After-hours: Jun 16, 2025, 07:38 PM EDT
Sonnet BioTherapeutics Revenue
Sonnet BioTherapeutics reported an annual revenue of $18.63K, reflecting a -87.4% growth. For the quarter ending March 31, 2025, Sonnet BioTherapeutics generated $0 in revenue.
Revenue (ttm)
$18.63K
Revenue Growth
-87.4%
Price / Sales Ratio
235.35
Revenue / Employee
$1.43K
Employees
13
Market Cap
3.67M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|